These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7932560)

  • 21. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
    Tsai BS; Keith RH; Villani-Price D; Kachur JF; Yang DC; Djuric SW; Yu S
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
    Jackson RH; Morrissey MM; Sills MA; Jarvis MF
    J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analogues.
    Boehm JC; Gleason JG; Pendrak I; Sarau HM; Schmidt DB; Foley JJ; Kingsbury WD
    J Med Chem; 1993 Oct; 36(22):3333-40. PubMed ID: 8230123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes.
    Goldman DW; Gifford LA; Olson DM; Goetzl EJ
    J Immunol; 1985 Jul; 135(1):525-30. PubMed ID: 2987349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotriene B4 Inhibits L-Type Calcium Channels via p38 Signaling Pathway in Vascular Smooth Muscle Cells.
    Liu X; Yang T; Miao L; Mei YA; Hu C
    Cell Physiol Biochem; 2015; 37(5):1903-13. PubMed ID: 26584289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
    Griffiths RJ; Pettipher ER; Koch K; Farrell CA; Breslow R; Conklyn MJ; Smith MA; Hackman BC; Wimberly DJ; Milici AJ
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):517-21. PubMed ID: 7831322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
    van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
    Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
    Showell HJ; Conklyn MJ; Alpert R; Hingorani GP; Wright KF; Smith MA; Stam E; Salter ED; Scampoli DN; Meltzer S; Reiter LA; Koch K; Piscopio AD; Cortina SR; Lopez-Anaya A; Pettipher ER; Milici AJ; Griffiths RJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):946-54. PubMed ID: 9618393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential fatty acids are antagonists of the leukotriene B4 receptor.
    Yagaloff KA; Franco L; Simko B; Burghardt B
    Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):293-7. PubMed ID: 7630916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships.
    Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.
    Mong S; Chi-Rosso G; Miller J; Hoffman K; Razgaitis KA; Bender P; Crooke ST
    Mol Pharmacol; 1986 Sep; 30(3):235-42. PubMed ID: 3018480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.
    Jackson WT; Boyd RJ; Froelich LL; Gapinski DM; Mallett BE; Sawyer JS
    J Med Chem; 1993 Jun; 36(12):1726-34. PubMed ID: 8389876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.
    Herron DK; Goodson T; Bollinger NG; Swanson-Bean D; Wright IG; Staten GS; Thompson AR; Froelich LL; Jackson WT
    J Med Chem; 1992 May; 35(10):1818-28. PubMed ID: 1316967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain.
    Gapinski DM; Mallett BE; Froelich LL; Jackson WT
    J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
    Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of structural analogues of leukotriene B4 and their receptor binding activity.
    Konno M; Nakae T; Sakuyama S; Nishizaki M; Odagaki Y; Nakai H; Hamanaka N
    Bioorg Med Chem; 1997 Aug; 5(8):1621-47. PubMed ID: 9313867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site.
    Cheng JB; Cheng EI; Kohi F; Townley RG
    J Pharmacol Exp Ther; 1986 Jan; 236(1):126-32. PubMed ID: 3001280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.